Sponsor or institution
Clinical trials and research at Shanghai Hutchison Pharmaceuticals Limited
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Shanghai Hutchison Pharmaceuticals Limited that are recruiting, in China. By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
SHPL-49 injection for treating acute ischemic stroke (Phase III)
This trial tests whether a seven-day course of intravenous SHPL-49 helps adults with acute ischemic stroke who receive thrombolysis within eight hours of symptom onset.
-
Evaluating the effectiveness of Danning Tablets for digestive symptoms
This study is testing if Danning Tablets can help people aged 18 to 75 feel better from digestive issues like indigestion and bloating while they are already using the medication.
Quick answers
How many clinical trials run by Shanghai Hutchison Pharmaceuticals Limited are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.